For more information on AXIM Biotechnologies and their products, visit http://aximbiotech.com/.

CanChew® and AXIM® Biotechnologies were part of a news segment on CBS Sacramento entitled “Solution To Opioid Epidemic May Come From Cannabis”. Axim has filed a patent involving a novel chewing gum composition developed for the controlled release of cannabinoids and opioid agonists and/or antagonists for treatment of addiction and dependance. The chewing gum also has potential to be used for treatment of chronic pain. This patent application is the first step in creating a cannabinoid-based treatment for opioid addiction. By providing replacement opioids such as opioid agonists and/or antagonists and cannabinoids in a chewing gum form, AXIM® Biotechnologies aims to minimize dependency and the effects of opioid withdrawal in patients.

AXIM® Biotechnologies is an innovative biotechnology company focusing on the research, development, and production of cannabinoid-based pharmaceuticals and nutraceutical supplements.

source